Skip to main content
Premium Trial:

Request an Annual Quote

Genomic Solutions Sells ProGest Unit to University of Calgary

NEW YORK, Oct. 24 - Genomic Solutions has sold one of its Investigator ProGest protein digestion station to the University of Calgary, the company said on Wednesday.

Although Genomic Solutions did not disclose the purchase price of the device, it said the unit is a “major system” that is worth “$25,000 or more.”

The neuroscience research group from the university’s department of physiology and biophysics purchased the ProGest, which automates the digestion of proteins in gel plugs, according to Genomic Solutions. The school currently owns other Investigator products, including a 2-D electrophoresis system and a ProPic robotic workstation, the Ann Arbor, Mich.-based company said.

Earlier this month, in an effort to trim costs, the microarray and proteomics company sold off its proteomics contract services business to a newly formed company, Proteomic Research Services.

"This action will significantly reduce our cost structure with minimal lost revenue impact," Jeffrey Williams, CEO of Genomics Solutions, said in a statement on Oct. 3. "Our 2000 revenue associated with proteomic contract services was less than 5 percent of sales." 

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.